Lenacapavir Steals the Show at AIDS 2024
Yvette and Ben meet Gilead’s Dr. Moupali Das to discuss the latest clinical trial results for a new prevention technology that reduces HIV transmission by 100 percent in women. How did the research go and what plans does the company have to provide for the 100s of thousands of girls and women in need across Africa?
